Madrigal faces financial challenges and competition for Rezdiffra. Read more to understand why MDGL stock is downgraded from ...
Dupixent (dupilumab) is tipped to be the market ... Sanofi says there has been more than 200 applications to receive the drug under the system, which ceases once a drug gains marketing approval.
Diana Taurasi is still mulling over her decision whether to play another season in the WNBA or retire. The 20-year veteran ...
Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, drug pipeline outlook, the ...
Mike Sorrentino is a Senior Editor for Mobile, covering phones, texting apps and smartwatches -- obsessing about how we can make the most of them. Mike also keeps an eye out on the movie and toy ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Read here for three stocks that have consistently performed well and continue to impress with their earnings. They also offer ...
Immunology drug Dupixent is seeing very strong, steady growth in atopic dermatitis and asthma, and approvals continue to expend to new indications (nasal polyposis) and younger patients.
Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chronic obstructive ...
The Billboard 200 is the United States’ main albums chart, compiled by Billboard magazine based on sales and streams in the USA. View the full Billboard 200 here.
What does Nifty 200 represent? Represents the performance of 200 large-cap and mid-cap companies listed on the National Stock Exchange (NSE), providing a broader market coverage beyond the Nifty 50..
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...